Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flying Under the Radar: The Immunobiology of Hepatitis C
Lynn B. Dustin, Charles M. Rice
Annual Review of Immunology (2006) Vol. 25, Iss. 1, pp. 71-99
Closed Access | Times Cited: 323

Showing 1-25 of 323 citing articles:

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Peter Pushko, Paul Pumpens, Elmars Grens
Intervirology (2013) Vol. 56, Iss. 3, pp. 141-165
Open Access | Times Cited: 5894
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
Jennifer M. Timpe, Zania Stamataki, Adam Jennings, et al.
Hepatology (2007) Vol. 47, Iss. 1, pp. 17-24
Open Access | Times Cited: 370
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang, Marcus Dorner, Jannick Prentoe, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 16, pp. 6205-6210
Open Access | Times Cited: 324
Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro
Po‐Yuan Ke, Steve S.-L. Chen
Journal of Clinical Investigation (2010) Vol. 121, Iss. 1, pp. 37-56
Open Access | Times Cited: 323
Immune responses and immunopathology in acute and chronic viral hepatitis
Eui‐Cheol Shin, Pil Soo Sung, Su‐Hyung Park
Nature reviews. Immunology (2016) Vol. 16, Iss. 8, pp. 509-523
Closed Access | Times Cited: 308
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
Michael L. Washburn, Moses T. Bility, Liguo Zhang, et al.
Gastroenterology (2011) Vol. 140, Iss. 4, pp. 1334-1344
Open Access | Times Cited: 293
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
Debora Franceschini, Marino Paroli, Vittorio Francavilla, et al.
Journal of Clinical Investigation (2009) Vol. 119, Iss. 3, pp. 551-564
Open Access | Times Cited: 291
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
Mady Hornig, José G. Montoya, Nancy G. Klimas, et al.
Science Advances (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 233
A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitis
Michael C. Sneller, Zonghui Hu, Carol A. Langford
Arthritis & Rheumatism (2011) Vol. 64, Iss. 3, pp. 835-842
Open Access | Times Cited: 226
CD56 negative NK cells: origin, function, and role in chronic viral disease
Niklas K. Björkström, Hans‐Gustaf Ljunggren, Johan K. Sandberg
Trends in Immunology (2010) Vol. 31, Iss. 11, pp. 401-406
Closed Access | Times Cited: 239
Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells
Svetlana Marukian, Christopher T. Jones, Linda Andrus, et al.
Hepatology (2008) Vol. 48, Iss. 6, pp. 1843-1850
Open Access | Times Cited: 237
Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulence
Paul Schmid‐Hempel
Philosophical Transactions of the Royal Society B Biological Sciences (2008) Vol. 364, Iss. 1513, pp. 85-98
Open Access | Times Cited: 222
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use
Pin‐Yu Perera, Jack Lichy, Thomas A. Waldmann, et al.
Microbes and Infection (2011) Vol. 14, Iss. 3, pp. 247-261
Open Access | Times Cited: 210
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
Marija Zeremski, Lidija M. Petrovic, Andrew H. Talal
Journal of Viral Hepatitis (2007) Vol. 14, Iss. 10, pp. 675-687
Closed Access | Times Cited: 192
Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species
Robert Tacke, Hai-Chon Lee, Celeste Goh, et al.
Hepatology (2011) Vol. 55, Iss. 2, pp. 343-353
Open Access | Times Cited: 187
Pathogen subversion of cell-intrinsic innate immunity
Craig R. Roy, Edward S. Mocarski
Nature Immunology (2007) Vol. 8, Iss. 11, pp. 1179-1187
Closed Access | Times Cited: 172
Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity
Qiang Ding, Xuezhi Cao, Jie Lu, et al.
Journal of Hepatology (2013) Vol. 59, Iss. 1, pp. 52-58
Closed Access | Times Cited: 166
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
Svetlana Marukian, Linda Andrus, Timothy P. Sheahan, et al.
Hepatology (2010) Vol. 54, Iss. 6, pp. 1913-1923
Open Access | Times Cited: 165
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
Edgar D. Charles, Rashidah M. Green, Svetlana Marukian, et al.
Blood (2007) Vol. 111, Iss. 3, pp. 1344-1356
Open Access | Times Cited: 164
The Interferon Inducible Gene: Viperin
Katherine A. Fitzgerald
Journal of Interferon & Cytokine Research (2010) Vol. 31, Iss. 1, pp. 131-135
Open Access | Times Cited: 157
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
Maria Teresa Catanese, Rita Graziani, Thomas von Hahn, et al.
Journal of Virology (2007) Vol. 81, Iss. 15, pp. 8063-8071
Open Access | Times Cited: 151
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
Jannick Prentoe, Tanja B. Jensen, Philip Meuleman, et al.
Journal of Virology (2010) Vol. 85, Iss. 5, pp. 2224-2234
Open Access | Times Cited: 144
Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges
Michael J. Bouchard, Sonia Navas
Cancer Letters (2010) Vol. 305, Iss. 2, pp. 123-143
Open Access | Times Cited: 141
Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses
Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, et al.
Gastroenterology (2011) Vol. 141, Iss. 3, pp. 1067-1079
Open Access | Times Cited: 138
Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis
Mark A. A. Claassen, Robert J. de Knegt, Hugo W. Tilanus, et al.
Journal of Hepatology (2009) Vol. 52, Iss. 3, pp. 315-321
Closed Access | Times Cited: 138
Page 1 - Next Page

Scroll to top